SOURCE: Hansen Medical, Inc.

Hansen Medical, Inc.

February 26, 2015 17:00 ET

Hansen Medical® Announces Completion of First Clinical Procedures With the Magellan™ Robotic System in the Middle East

MOUNTAIN VIEW, CA--(Marketwired - Feb 26, 2015) - Hansen Medical®, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first clinical procedures with the Magellan Robotic System in the Middle East. The team led by Dr. Iyad Feteih, Interventional Radiologist and Assistant Hospital Director, performed five procedures with Magellan at King Fahd Hospital (MOH) in Jeddah, Kingdom of Saudi Arabia. The Magellan system was installed in late 2014 in collaboration with AFYA Medical Group, Hansen Medical's exclusive distribution partner in Kingdom of Saudi Arabia and United Arab Emirates.

"Congratulations to Dr. Feteih, Dr. Mandouh and Dr. Nayal and the team at King Fahd Hospital (MOH) on completion of the first Magellan procedures in the Middle East," said Cary Vance, Hansen Medical's President and Chief Executive Officer. "Through our partnership with AFYA, we expect that a large number of physicians and patients in Saudi Arabia and United Arab Emirates will be able to experience the benefits of intravascular robotic procedures."

The initial procedures at King Fahd Hospital (MOH) included Uterine Fibroid Embolization, treatment of lower extremity peripheral artery disease, and diagnostic angiography, and included use of both the 6Fr and the 9Fr Magellan Robotic Catheters.

"The Magellan Robotic System offers great potential to enable predictable treatment of patients seeking minimally-invasive treatment for vascular disease, and to reduce radiation exposure for physicians during endovascular procedures," said Dr. Feteih. "I am very pleased with our initial experience. We found the system to be user friendly, and the learning curve is quite short. We plan to use the system regularly, and we look forward to sharing our experiences with our peers in Saudi Arabia and the Gulf region."

The Magellan Robotic System is an advanced technology that drives the Magellan Robotic Catheters during endovascular procedures. Magellan is designed to offer procedural predictability, control, and catheter stability to physicians as they remotely navigate the robotic catheter through the vasculature. Magellan's remote workstation allows physicians to navigate through the vasculature while seated away from the radiation field, potentially reducing physicians' radiation exposure and procedural fatigue.

About the Magellan™ Robotic System
Hansen Medical's Magellan Robotic System is intended to be used to facilitate navigation in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Magellan Robotic System is designed to deliver predictability, control and catheter stability to endovascular procedures. Since its commercial introduction in the U.S. and Europe, the Magellan Robotic System has demonstrated its clinical versatility in many cases in a broad variety of peripheral vascular procedure types in centers across the U.S. and Europe. The Magellan Robotic System offers several important features including:

  • Provides predictability, control and catheter stability as a physician navigates a patient's peripheral vasculature and then provides a conduit for manual treatment of vascular disease with standard therapeutic devices.
  • Is designed to enable more predictable procedure times and increased case throughput potentially allowing hospitals to improve utilization within their vascular business line
  • Employs an open architecture designed to allow for the subsequent use of many therapeutic devices on the market today.
  • Is designed to potentially reduce physician radiation exposure and fatigue by allowing the physician to navigate procedures while seated comfortably at a remote workstation away from the radiation field and without wearing heavy lead as required in conventional endovascular procedures.
  • The Magellan 9Fr Robotic Catheter allows for independent, robotic control of the distal tip of two telescoping catheters (an outer Guide and an inner Leader catheter), as well as robotic manipulation of standard guide wires.
  • The Magellan 6Fr Robotic Catheter allows for independent robotic control of two separate bend sites on a single catheter, as well as robotic manipulation of standard guide wires. This smaller catheter design may be preferred by certain physicians who prefer a smaller diameter vessel access site, or in procedures in smaller vessels.

About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, is a global leader in Intravascular Robotics, developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The Company's Magellan™ Robotic System, 9Fr Magellan™ Robotic Catheter, Magellan™ 6Fr Robotic Catheter, and related accessories are intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Company's mission is to enable Cardiac Arrhythmia and Endovascular Procedures and to improve patient outcomes through the use of Intravascular Robotics. Additional information can be found at

"Hansen Medical," "Hansen Medical (with Heart Design)," "Heart Design (Logo)," are registered trademarks, and "Magellan" and "Hansen Medical Magellan" are trademarks of Hansen Medical, Inc. in the U.S. and other countries. All other trademarks are the property of their respective owners.